ALOCRIL Drug Patent Profile
✉ Email this page to a colleague
When do Alocril patents expire, and what generic alternatives are available?
Alocril is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in ALOCRIL is nedocromil sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nedocromil sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALOCRIL?
- What are the global sales for ALOCRIL?
- What is Average Wholesale Price for ALOCRIL?
Summary for ALOCRIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 43 |
Patent Applications: | 3,572 |
Drug Prices: | Drug price information for ALOCRIL |
What excipients (inactive ingredients) are in ALOCRIL? | ALOCRIL excipients list |
DailyMed Link: | ALOCRIL at DailyMed |
Pharmacology for ALOCRIL
Drug Class | Mast Cell Stabilizer |
Physiological Effect | Decreased Histamine Release |
US Patents and Regulatory Information for ALOCRIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALOCRIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ALOCRIL
See the table below for patents covering ALOCRIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
France | 2563105 | COMPOSITIONS POUR LES SOINS DES VOIES RESPIRATOIRES | ⤷ Sign Up |
Japan | 2504926 | ⤷ Sign Up | |
France | 2609392 | COMPOSITIONS PHARMACEUTIQUES CONTENANT DES PYRANOQUINOLEINES | ⤷ Sign Up |
Spain | 8707222 | PROCEDIMIENTO PARA LA OBTENCION DEL 9-ETIL-4,6-DIOXO-10-PROPIL-6,9-DIHIDRO-4H-PIRANO(3,2-G)QUINOLINA-2,8-DICARBOXILATO DE DIETILO (Process for obtaining diethyl 9-ethyl-4,6-dioxo-10-propyl- 6,9-dihydro-4H-pyrano[3,2-g]quinolene-2,8-dicarboxylate Process for obtaining diethyl 9-ethyl-4,6-dioxo-10-propyl- 6,9-dihydro-4H-pyrano[3,2-g]quinolene-2,8-dicarboxylate) | ⤷ Sign Up |
Japan | H01199909 | PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRANOQUINOLINE DERIVATIVE | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |